Design Therapeutics Inc

Gesloten

15.5 6.31

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

14.75

Max

15.63

Belangrijke statistieken

By Trading Economics

Inkomsten

-1.6M

-18M

EPS

-0.29

Werknemers

54

EBITDA

534K

-17M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+32.67% upside

Dividenden

By Acuity

Volgende Winsten

5 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

90M

889M

Vorige openingsprijs

9.19

Vorige sluitingsprijs

15.5

Design Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

3 jul 2026, 23:52 UTC

U.S. job growth disappoints, reducing Fed rate hike expectations, while global equities rise amid easing U.S.-Iran tensions and stable oil prices.

3 jul 2026, 23:52 UTC

European equity indices rise as weaker U.S. job growth dampens Fed rate hike expectations, while ECB signals caution amid mixed economic indicators.

3 jul 2026, 23:52 UTC

Global equity markets rise as U.S. job growth disappoints and European economic indicators show mixed signals, prompting cautious outlook on interest rate hikes.

3 jul 2026, 23:52 UTC

Asia equity markets rise as U.S. jobs data eases Fed rate hike concerns, boosting sentiment and commodities like gold and oil.

3 jul 2026, 23:52 UTC

Brazil's Inflation Rate Release on July 10, 2026: Market Awaits Insights Amid World Cup Spending Boost and Economic Uncertainty.

3 jul 2026, 23:52 UTC

Brazil's Inflation Rate Release on July 10, 2026: Market Eyes Potential Shifts Amid Service Sector Growth and Global Pressures.

3 jul 2026, 23:41 UTC

Spain's Consumer Confidence Index Holds Steady at 77.7 Amid Geopolitical Tensions and Inflation Concerns

3 jul 2026, 23:41 UTC

Correlated Moves
Macro News

Bitcoin is gaining ground amid improved sentiment following a weaker U.S. jobs report, which has eased expectations for Federal Reserve interest rate hikes.

3 jul 2026, 23:31 UTC

Mexico's June 2026 Inflation Rate Release on July 9 Expected Amid Cautious Optimism Over Global Price Trends.

3 jul 2026, 23:31 UTC

Mexico's Inflation Rate MoM Release on July 9, 2026: Market Anticipates Impact from U.S. Monetary Policy Adjustments and Global Economic Pressures.

3 jul 2026, 23:22 UTC

U.S. Balance of Trade Report Set for July 7, Anticipating $78.8 Billion Deficit Amid Labor Market Concerns and Global Economic Volatility

3 jul 2026, 23:22 UTC

U.S. Imports Data Release on July 7, 2026: Analysts Anticipate Cautious Optimism Amid Tariff Influences and Supply Chain Concerns

3 jul 2026, 23:22 UTC

U.S. Exports Data Release on July 7, 2026, Expected to Show Continued Growth Amid Geopolitical Tensions and Trade Policy Changes

3 jul 2026, 23:22 UTC

Canada's Trade Balance Expected to Show C$2.4 Billion Surplus Amid Optimism in Export Performance and Market Uncertainty Over U.S. Trade Relations

3 jul 2026, 23:21 UTC

Correlated Moves

The Russell 2000 Index is trading lower in after-market hours, reflecting a broader market decline linked to disappointing U.S. job growth data.

3 jul 2026, 23:21 UTC

Correlated Moves

The S&P 500 Index is trading lower in after-market hours, reflecting minimal movement since Friday's close amid weaker U.S. jobs data.

3 jul 2026, 23:21 UTC

Nasdaq 100 Index declines slightly in after-market trading, remaining flat overall. Recent U.S. nonfarm payrolls report eases interest rate hike concerns.

3 jul 2026, 23:21 UTC

Correlated Moves

The Dow Jones Index is trading lower in after-market hours, reflecting a weak performance since Friday's close amid disappointing U.S. nonfarm payrolls data.

3 jul 2026, 23:21 UTC

The FTSE 100 Index is trading lower in after-market hours, with no specific news identified to explain the decline.

3 jul 2026, 23:11 UTC

Brazil's Retail Sales MoM report on July 8, 2026, signals cautious market sentiment amid recent declines and economic uncertainty.

3 jul 2026, 23:11 UTC

Correlated Moves

XRP is trading higher, buoyed by positive sentiment in the digital currency market and softer U.S. nonfarm payrolls data impacting interest rate expectations.

3 jul 2026, 23:11 UTC

Correlated Moves
Macro News

Ethereum is trading higher since Thursday, supported by increased interest in Pepeto and a correlated rise in Bitcoin. Earlier, it pulled back from a session high.

3 jul 2026, 23:01 UTC

Declining 30-Year Mortgage Rates Signal Potential Boost in U.S. Housing Market Confidence and Activity

3 jul 2026, 23:01 UTC

Terra is trading higher during Friday's session, maintaining upward momentum since Thursday. No specific news has been identified to explain this price movement.

3 jul 2026, 23:01 UTC

Cardano is trading higher today, continuing a notable increase since Thursday's close. The asset remains above its 20-day moving average.

3 jul 2026, 22:51 UTC

Brazil's Central Bank to Release Key Interest Rate Insights Amid Global Economic Influences on July 6, 2026.

3 jul 2026, 22:51 UTC

Japan's Current Account data release on July 7, 2026, forecasts a JPY 4.1 trillion surplus amid cautious market sentiment and potential currency volatility concerns.

3 jul 2026, 22:51 UTC

The DAX 30 Index is trading lower in after-market hours, with no specific news identified. Recent U.S. jobs data may be influencing market sentiment.

3 jul 2026, 22:31 UTC

UK Housing Market Faces Negative Outlook as RICS House Price Balance Forecasts -0.32% Amid Economic Pressures and Inflation Concerns

3 jul 2026, 22:11 UTC

Japan's Household Spending Data Set for Release Amidst Declining Consumer Confidence and Currency Market Volatility

Peer Vergelijking

Prijswijziging

Design Therapeutics Inc Prognose

Koersdoel

By TipRanks

32.67% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 20.75 USD  32.67%

Hoogste 22 USD

Laagste 20 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Design Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Design Therapeutics Inc

Design Therapeutics, Inc. a biopharmaceutical company, researches, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion. Its lead product candidates for potentially disease-modifying treatment comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function that brings to neurological, cardiac, and metabolic dysfunction; Myotonic Dystrophy Type-1, a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs; Fuchs Endothelial Corneal Dystrophy, a genetic eye disease characterized by bilateral degeneration of corneal endothelial cells and progressive loss of vision; and Huntington's Disease, a dominantly inherited, monogenic neurodegenerative disease characterized by movement, cognitive, and psychiatric disorders. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
help-icon Live chat